inicio > >

Mas artículos relacionados   

Artículo del Mes


Título:

Tuberculosis epidemiology and control in Veracruz, Mexico.


Autor(es):

Garcia-Garcia ML, Small PM, Garcia-Sancho C, Mayar-Maya ME, Ferreyra-Reyes L, Palacios-Martinez M, Jimenez S, Canales G, Quiroz G, Yanez L, Valdespino-Gomez JL.


Fuente:

Int J Epidemiol. 1999 Feb;28(1):135-40.


Resumen:

BACKGROUND: Tuberculosis (TB) rates remain high in regions of Southern Mexico despite the existence of a National Tuberculosis Program. Understanding TB epidemiology in such settings would assist in the design of improved TB control and highlight the challenges confronting TB control in developing countries. METHODS: We conducted a retrospective review of treatment control cards from 1991 to 1994 in five municipalities in a semiurban region of Southern Mexico. RESULTS: The relatively high rate of TB observed, 42.6 per 100,000 inhabitants, did not change significantly during the study period. Cure rates among new cases were 79% and significantly lower among retreatment cases (62%). Directly observed therapy (DOT) was administered to 84% of patients. Approximately one-half of the retreatment cases who were not cured were compliant with therapy, suggesting that drug resistance contributed to these poor results. Of particular concern was a core group of 16 patients who had received at least three treatments. CONCLUSIONS: This region of Mexico has persistently high TB rates despite a DOT-based TB control programme which achieves an overall cure rate of 77%. There exist many retreatment cases for whom cure rates are significantly lower. These cases may serve as a core group for the dissemination of drug resistant TB. The control programme is being reinforced by a nominal register of patients, decreasing administrative barriers for drug supply to individual patients and the availability of mycobacteria cultures. In addition to these measures, in regions which are approaching the levels of efficacy recommended by the WHO it may be appropriate to consider focusing efforts on the identification and treatment of chronic cases.


Ver texto completo

 

Bibliografía Seleccionada

1.
 Fuente: Rev Invest Clin. 2001 Sep-Oct;53(5):460-1.
2.
 Fuente: Gac Med Mex. 2003 Sep-Oct;139(5):471-92.
3.
 Fuente: Int J Tuberc Lung Dis. 2000 Jan;4(1):12-7.
4.
 Fuente: Arch Intern Med. 2000 Mar 13;160(5):630-6.
5.
 Fuente: Gac Med Mex. 2001 Jan-Feb;137(1):93-4.
6.
 Fuente: Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S168-70.
7.
 Fuente: Diabetes Care. 2004 Jul;27(7):1584-90.
8.
 Fuente: Rev Panam Salud Publica. 2004 Jul;16(1):23-34.
9.
 Fuente: J Clin Microbiol. 2004 Dec;42(12):5512-6.
10.
 Fuente: Trop Med Int Health. 2005 Apr;10(4):305-11.

 


Enlaces de Interes

1.
2.

 

 

Instituto Nacional en Salud Pública
Centro de Información en Decisiones en Salud Pública - CENIDSP
Cuernavaca, Mor. México
Tel: +52(777)3293000 • Fax: +52(777)3293000
Aviso Legal BVS México